 |
 | |
 |  |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
(ADMP) Market Cap $33 million--Cash $17 M --FDA Decision on Oct.31 for ZIMHI a treatment of opioid overdose which is a large market --company has already one marketed drug for the treatment of anaphylaxis launched early this year and partnered with Sandoz(Novartis) targeting a $1.5 BILLION Market .Current valuation of $33million is a PURE GIFT for this company a potential 10 bagger here . STRONG BUY SUPER AGGRESSIVE Admamis Pharma (ADMP) Market-Cap:$33 million Cash: $17 million Price: $0.54 Presentation ir.adamispharmaceuticals.com ZIMHI (naloxone) injection Indication–Opioid Overdose Addressable Market -$330 million FDA action date Oct. 31, 2019 SYMJEPI (epinephrine) injection Indication-Anaphylaxis Addressable Market -$1.5 billion Launched–January 2019 First products using patented, FDA-approved injection device Both doses (0.3mg and 0.15mg) are FDA approved Sandoz a division of Novartis –commercial partner in U.S. Commercial deal terms –50% of net profits, upfront fee and potential performance-based milestone payments Exploring potential licensing options for ex-US territories Near-Term Target Milestones FDA action date (PDUFA) of Oct. 31, 2019 on NDA for ZIMHI Pursuing potential partnerships for SYMJEPI (ex-US) and ZIMHI product candidate Continued launch of SYMJEPI in U.S. –retail and SYMJEPI low dose launches pending  Largest Shareholders : Heights Capital...3.0M 683 Capital ...2.4M The Vanguard ...1.8M First Manhattan...1.4M BlackRock...952.8K Morgan Stanley...625.7K Geode Capital...337.2K Carlo (Dennis J)...292.3K Moss (Ronald B)...285.0K GSA Capital...139.6K | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |